Skip to content

Clinical trials

Completed Phase 2/3 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 2/3 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20171
20204
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
APR Applied Pharma Research s.a.1
Boehringer Ingelheim1
Fayoum University1
NICHD Neonatal Research Network1
NeuroBo Pharmaceuticals Inc.1
Regeneron Pharmaceuticals1
University of Alabama at Birmingham1
University of Athens1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome9
COVID-193
Premature Birth3
Bronchopulmonary Dysplasia2
Coronavirus Infections2
Acute Lung Injury1
Infections1
Respiratory Aspiration1
Respiratory Insufficiency1
Ventilator-Induced Lung Injury1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.